Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Sierra Oncology Inc. SRRA

Healthcare Biotechnology
Sierra Oncology Inc is a clinical-stage drug development company. It focuses on the research, development, and commercialization of DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer in the United States and internationally. The company's lead drug candidate is SRA737, an orally bioavailable small molecule inhibitor of Checkpoint kinase 1, which is in Phase 1... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SRRA)

No current news is available.
View More News ››

Opinion & Analysis (NDAQ:SRRA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:SRRA)

5 REASONS TO ADD SIERRA ONCOLOGY TO YOUR PORTFOLIO

5 REASONS TO ADD SIERRA ONCOLOGY TO YOUR PORTFOLIO $SRRA Sierra Oncology, Inc. (NASDAQ: SRRA) a late-stage biopharmaceutical...
AviseAnalytics - January 28, 2022

My to tongue is out like Micheal Jordan 😝😛😜🤑🤑🤑

Float like a butterfly sting like a buzzing black Box on them opps!
sneakysneaky - January 26, 2022

it's a buy today for me

at.83 cents per share,so glta.
coolfooldumbguy - June 5, 2019
View more Bullboard ››

Tidal Care Inc.

Tidal Care Inc.

Tidal Care aims to be a high-compliance supplier of finished, formulated Psilocybin- and MDMA-based drug products to the ...
View More »